Tasmania Expands Childhood Vaccinations for Pharmacists

Expanded Childhood Immunisation Access in Tasmania

Tasmanian children aged two to five years will now have access to the 2026 influenza vaccine through their local pharmacist, following an expansion of the Tasmanian Authorised Pharmacist Immuniser and Program Guidelines. The changes, implemented yesterday, likewise broaden the range of vaccines pharmacist immunisers can administer to children between five and ten years old. This move is being hailed as a significant step towards improving childhood vaccination rates across the state, particularly as Australia prepares for the winter season.

The Pharmaceutical Society of Australia (PSA) has welcomed the broadened access, noting the potential to alleviate pressure on traditional vaccination providers and reduce barriers for families. Joanne Gross, PSA Tasmania President, highlighted the frustration experienced by parents previously needing to visit multiple healthcare providers to ensure complete family vaccination. These changes aim to streamline the process, making it easier for families to stay protected.

What the Changes Mean for Tasmanian Families

For parents, the expanded program means increased convenience and accessibility when it comes to protecting their children against preventable diseases. Pharmacists, as readily available healthcare professionals, can now play a larger role in delivering routine childhood vaccinations. This is particularly critical given the requirements for pharmacists to be authorised as an API to independently initiate vaccination.

The initial focus is on influenza vaccination for children aged two to five, with a broader range of vaccines becoming available for those aged five to ten. This phased approach allows for a smooth implementation and ensures pharmacist immunisers are equipped to handle the expanded scope of practice. It’s important to note that pharmacists must be appropriately trained and authorised to administer these vaccines.

Addressing Declining Vaccination Rates

The timing of these changes is crucial, as Australia continues to grapple with declining vaccination rates in certain population groups. Influenza, in particular, poses a significant public health threat, with last year’s season being the deadliest in the country this century. Annual influenza vaccination is recommended for everyone aged six months and older. Increasing access through pharmacies is seen as a key strategy to reverse this trend and protect vulnerable individuals.

However, the PSA is advocating for further expansion of the program. They are urging the Tasmanian government to adopt the Australian Immunisation Handbook as the standard formulary for Tasmanian pharmacist immunisers. This would allow pharmacists to initiate and administer all vaccines within their scope of practice, aligning Tasmania with recent regulatory changes in South Australia and Queensland.

The Australian Immunisation Handbook and Scope of Practice

The Australian Immunisation Handbook is the authoritative resource on immunisation in Australia, providing comprehensive guidance on vaccine schedules, administration techniques, and contraindications. Adopting this handbook as the standard for pharmacist immunisers would empower them to provide a wider range of vaccination services, potentially further improving access and coverage rates. The PSA points out that this aligns with pre-election commitments made by the Tasmanian government.

Currently, the scope of practice for pharmacist immunisers in Tasmania is defined by the Authorised Pharmacist Immuniser and Program Guidelines. Expanding this scope to encompass the full range of vaccines outlined in the Immunisation Handbook would require regulatory changes and potentially additional training for pharmacists. The PSA is actively working with the government to facilitate this process.

Looking Ahead: Continued Collaboration and Expansion

The PSA’s Tasmanian President, Joanne Gross, emphasized the demand for ongoing collaboration between the government, pharmacists, and other healthcare professionals to ensure the success of the expanded program. She also highlighted the potential for pharmacists to play a role in providing travel vaccinations, further enhancing their contribution to public health.

The changes in Tasmania reflect a broader trend towards expanding the role of pharmacists in primary healthcare. As trusted and accessible healthcare providers, pharmacists are well-positioned to deliver a range of services, including vaccinations, medication reviews, and health screenings. This shift has the potential to improve health outcomes and reduce the burden on the broader healthcare system.

Next Steps: Monitoring and Evaluation

The Tasmanian Department of Health will be closely monitoring the impact of these changes on vaccination rates and access. Regular evaluations will be conducted to assess the effectiveness of the program and identify any areas for improvement. This data will inform future policy decisions and ensure that the program continues to meet the needs of the Tasmanian community. Further regulatory updates are anticipated as the government works towards fulfilling its commitment to align the pharmacist immuniser formulary with the Australian Immunisation Handbook.